• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

A. James Moser, MD, FACS


  • Kim CH, Ling DC, Wegner RE, Flickinger JC, Heron DE, Zeh H, Moser AJ, Burton SA.Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients.Radiat Oncol. 2013;8:240.
  • Daouadi M, Zureikat AH, Zenati MS, Choundry MA, Tsung A, Bartlett DL, Hughes SH, Lee KK, Moser AJ* (equal contribution), Zeh HJ III.Robot-Assisted Minimally-Invasive Distal Pancreatecomy is Superior to the Laparoscopic Technique. Annals of Surgery.Ann Surg..
  • Baumgartner JM, Krasinskas A, Dauoadi M, Zureikat A, Marsh JW, Lee KKL, Bartlett DL, Moser AJ*, Zeh HJ III.Distal pancreatectomy with en bloc celiac axis resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy.J Gastrointest Surg..
  • Bottino R, Bertera S, Grupillo M, Melvin PR, Humar A, Mazariegos G, Moser AJ, Walsh RM, Fung J, Gelrud A, Slivka A, Soltys K, Wijkstrom M, Trucco M.Isolation of human islets for autologous islet transplantation in children and adolescents with chronic pancreatitis.Transplantation..
  • Lepisto AJ, Moser AJ, Zeh H, Lee K, Bartlett D, McKolanis JR, Geller BA, Schmotzer A, Potter DP, Whiteside T, Finn OJ, Ramanathan RK.A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.Cancer Ther. 2008;6(B):955-964.
  • Bao PQ, Ramanathan RK, Krasinkas A, Bahary N, Lembersky BC, Bartlett DL, Hughes SJ, Lee KK, Moser AJ*, Zeh HJ 3rd.Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.Ann Surg Oncol..
  • Demeure MJ, Sielaff T, Koep L, Prinz R, Moser AJ, Zeh H, Hostetter G, Black J, Decker A, Rosewell S, Bussey KJ, Von Hoff D.Multi-institutional tumor banking: lessons learned from a pancreatic cancer biospecimen repository.Pancreas. 2010 Oct;39(7):949-54. Review.
  • Sanders MK, Moser AJ, Khalid A, Fasanella KE, Zeh HJ, Burton S, McGrath K.EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer.Gastrointest Endosc. 2010 Jun;71(7):1178-84.
  • Franko J, Greer JB, Moran CM, Khalid A, Moser AJ.Multimodality therapy for pancreatic cancer.Gastroenterol Clin North Am. 2007 Jun;36(2):391-411, x. Review.
  • Khalid A, McGrath KM, Zahid M, Wilson M, Brody D, Swalsky P, Moser AJ, Lee KK, Slivka A, Whitcomb DC, Finkelstein S.The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology.Clin Gastroenterol Hepatol. 2005 Oct;3(10):967-73.
  • Whitcomb DC, Khalid A, Slivka A, McGrath K, Moser AJ, Bell RH.Conference report for APA postgraduate course: clinical controversies in pancreatobiliary diseases.Pancreas. 2005 Oct;31(3):218-20.
  • Ramanathan RK, Lee KM, McKolanis J, Hitbold E, Schraut W, Moser AJ, Warnick E, Whiteside T, Osborne J, Kim H, Day R, Troetschel M, Finn OJ.Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.Cancer Immunol Immunother. 2005 Mar;54(3):254-64.
  • Cheung O, Kandil H, Moser AJ, Swalsky PA, Sasatomi E, Finkelstein SD.Primary duodenal carcinoma showing divergent growth patterns as determined by microdissection-based mutational genotyping.Arch Pathol Lab Med. 2003 Jul;127(7):861-4.
  • Moser AJ.Benign Biliary Strictures.Curr Treat Options Gastroenterol. 2001 Oct;4(5):377-387.
  • Moser AJ, Abedin MZ, Roslyn JJ.The pathogenesis of gallstone formation.Adv Surg. 1993;26:357-86. Review.